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Hogan, Michael C., L. Bruce Gladden, Bruno Grassi,
Creed M. Stary, and Michele Samaja. Bioenergetics of
contracting skeletal muscle after partial reduction of blood
flow. J. Appl. Physiol. 84(6): 1882–1888, 1998.—The purpose
of this study was to examine the bioenergetics and regulation
of O2 uptake (V˙O2) and force production in contracting muscle
when blood flow was moderately reduced during a steady-
state contractile period. Canine gastrocnemius muscle (n 5 5)
was isolated, and 3-min stimulation periods of isometric,
tetanic contractions were elicited sequentially at rates of
0.25, 0.33, and 0.5 contractions/s (Hz) immediately followed
by a reduction of blood flow [ischemic (I) condition] to 46 6 3%
of the value obtained at 0.5 Hz with normal blood flow. The
V˙O2 of the contracting muscle was significantly (P , 0.05)
reduced during the I condition [6.5 6 0.8 (SE) ml·100
g21 ·min21] compared with the same stimulation frequency
with normal flow (11.2 6 1.5 ml·100 g21 ·min21), as was the
tension-time index (79 6 12 vs. 123 6 22 N·g21 ·min21,
respectively). The ratio of V˙O2 to tension-time index remained
constant throughout all contraction periods. Muscle phospho-
creatine concentration, ATP concentration, and lactate efflux
were not significantly different during the I condition com-
pared with the 0.5-Hz condition with normal blood flow.
However, at comparable rates of V˙O2 and tension-time index,
muscle phosphocreatine concentration and ATP concentra-
tion were significantly less during the I condition compared
with normal-flow conditions. These results demonstrate that,
in this highly oxidative muscle, the normal balance of O2
supply to force output was maintained during moderate
ischemia by downregulation of force production. In addition,
1) the minimal disruption in intracellular homeostasis after
the initiation of ischemia was likely a result of steady-state
metabolic conditions having already been activated, and 2)
the difference in intracellular conditions at comparable rates
of V˙O2 and tension-time index between the normal flow and I
condition may have been due to altered intracellular O2
tension.
oxygen uptake; exercise; adenosine 58-triphosphate; lactate;
lactic acid; mitochondrial respiration; phosphocreatine; gly-
colysis
IN MOST CONDITIONS of steady-state muscle contractile
activity, ATP production related to the O2 uptake (V˙O2)
of the contracting muscle is tightly coupled to the rate
of ATP demand so that steady-state energy expenditure
is maintained with minimal change in intracellular
ATP concentration ([ATP]; e.g., see Ref. 12). When the
supply of O2 (and oxidative substrate) to the mitochon-
dria is sufficient, increases in myofibril ATPase activity
with higher energy demands result in changes in the
concentration of several signals [phosphocreatine (PCr),
ADP, Pi, etc.] that are thought to regulate mitochon-
drial respiration (4, 5, 18, 20, 22) in a manner that
causes oxidative phosphorylation to increase proportion-
ally with ATPase activity. However, when the supply of
O2 to the mitochondria is insufficient, the tight coupling
between the ATP demand of the myofibril ATPases and
the ATP supply by mitochondrial respiration may be
disrupted, and an increased reliance on ATP regenera-
tion derived from substrate-level phosphorylation (PCr
hydrolysis and anaerobic glycolysis) may ensue. The
result of prolonged mitochondrial O2 limitation can be a
downregulation of ATPase activity, thereby reducing
force development, so that ATP demand does not exceed
the reduced ATP production.
When mitochondrial O2 limitation is caused by re-
duced O2 availability due to inadequate blood flow
(ischemia), there is evidence that the manner in which
the blood flow reduction is imposed may influence
muscle metabolism and the degree of impairment of
contractile function (12, 16, 17, 31). Timmons et al.
(28–30) recently demonstrated that substrate availabil-
ity through the pyruvate dehydrogenase complex (PDC)
for carbohydrate oxidation in the tricarboxylic cycle can
affect subsequent muscle performance during moder-
ate ischemia. These investigators (30) demonstrated
that having the PDC enzyme fully activated at the
onset of an ischemic contractile period resulted in
significantly less PCr hydrolysis and lactate accumula-
tion and subsequently less fatigue compared with the
same ischemic blood flow reduction with PDC starting
from the normal resting deactivated state.
Although there has been extensive investigation of
the coupling of cell respiration to force production
under conditions of adequate O2 availability to the
mitochondria, there has been substantially less re-
search done concerning the manner in which muscle
reestablishes steady-state conditions when O2 availabil-
ity becomes limiting. The purpose of the present study
was to investigate the control of coupling of muscle
force output to the rate of mitochondrial respiration
when the O2 supply to the mitochondria was insuffi-
cient to meet the energy demand. In addition, we tested
the hypothesis that having the muscle in an aerobic
steady state of contractile activity with normal blood
flow, in which the PDC and other regulatory enzymes
were fully activated, would minimize the metabolic
disruption when partial ischemia was induced.
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METHODS
Five adult mongrel dogs of either sex with a weight range of
12–19 kg were anesthetized with pentobarbital sodium (30
mg/kg). Maintenance doses were given as required. The dogs
were intubated with cuffed endotracheal tubes, and ventila-
tion was maintained with a Harvard 613 ventilator at a rate
that achieved normal values of arterial PO2 and PCO2. Esopha-
geal temperature was maintained near 37°C by the use of
heating pads. The animals were given heparin at a dosage of
1,500 U/kg after the surgery.
Surgical preparation. The left gastrocnemius-flexor digi-
torum superficialis muscle complex (for convenience referred
to as gastrocnemius) was isolated as described previously
(15). Briefly, the muscle was isolated from nearby muscle
groups, and all vessels draining into the popliteal vein except
for those from the gastrocnemius were ligated to isolate the
venous outflow from the gastrocnemius. The arterial circula-
tion to the gastrocnemius was isolated by ligating all vessels
from the femoral and popliteal artery that did not enter the
gastrocnemius. The left popliteal vein was cannulated, and
the venous outflow from the isolated muscle was returned to
the animal via a jugular catheter.
The right femoral artery was catheterized for arterial blood
sampling. This catheter was connected to the left femoral
artery so that the isolated muscle was perfused by blood from
this contralateral artery. Perfusion was accomplished either
directly from the contralateral (systemic pressure, self-
perfused) or via a Sigmamotor pump to control flow. All
experimental conditions were conducted with blood flow
perfusion controlled by the pump. A pressure transducer in
this line at the head of the muscle constantly monitored
perfusion pressure. A carotid artery was also catheterized to
monitor systemic blood pressure. The left sciatic nerve, which
innervates the gastrocnemius, was doubly ligated and cut
between ties. To prevent cooling and drying, all exposed
tissues were covered with saline-soaked gauze and with a
sheet of Saran. After the muscle was surgically isolated, the
Achilles tendon was attached to an isometric myograph to
measure force development.
The hindlimb was fixed at the knee and ankle and attached
to the myograph with struts to minimize movement. Weights
were used at the end of each experiment to calibrate the force
myograph. The isometric force developed by each muscle was
normalized to the weight of that muscle. Before each contrac-
tion period, the resting muscle was passively stretched until
the force produced by a single tetanic contraction was maxi-
mal.
Experimental protocol. Isometric muscle contractions (te-
tanic) were elicited by stimulation of the sciatic nerve with
square-wave impulses (6–8 V) of 0.2-ms duration at a rate of
50 impulses/s, with this train of impulses lasting 0.2 s (so 10
impulses during each contraction). Each muscle (n 5 5) was
stimulated to contract in a consecutive manner for 3-min at
each of three stimulation frequencies: one contraction every 4
(0.25 Hz), 3 (0.33 Hz), and 2 (0.5 Hz) s. Muscle blood flow for
these three stimulation patterns was set at a rate that kept
muscle perfusion pressure at ,130 mmHg. After 3 min of the
0.5-Hz stimulation (highest contractile intensity; ,60–70%
of the peak V˙O2), the blood flow was immediately reduced by
,50% so that O2 delivery was reduced 50% [ischemia (I)].
Muscle force development was then allowed to stabilize at a
new steady state, which typically took ,3–4 min.
Measurements. Arterial blood samples from the arterial
line entering the muscle and venous samples from the left
popliteal vein as close to the gastrocnemius as possible were
drawn anaerobically at the end of each rest period, at the end
of each 3-min contraction period, and at the end of the
moderate-ischemia period. These samples were kept on ice for
the brief time before measurement. Venous blood flow mea-
surements were made at the same time the blood samples
were drawn by timed blood collections into a graduated
cylinder. Barbee et al. (1), using muscle contractions similar
to those used in this investigation, determined that a steady-
state flow and V˙O2 had been achieved by the end of 2 min.
Muscle biopsies were obtained immediately after the blood
measurements were taken. These biopsies were obtained by
using the Bergstrom needle-biopsy technique (3) and frozen
in liquid N2 within 2–4 s. In all, five biopsies were obtained
from each muscle from separate randomly selected sites (1 at
rest, 1 at the end of the 3 different stimulation periods, and 1
at the end of the I condition). The dog gastrocnemius is
composed of only high-oxidative fibers (type I and IIa; Ref.
19), with ,50% being slow oxidative (type I), so there should
be little variability in fiber type distribution throughout the
more superficial areas of the muscle where biopsy sampling
occurred. The muscle was removed and weighed at the end of
each experiment.
Muscle force development was measured from the chart
recordings and reported as newtons per 100 grams of muscle
mass. Muscle fatigue was calculated as the decline in muscle
force development with time and was reported as the tension
development at that time as a percentage of the initial
tension development for that condition. The tension-time
index was used as an indication of ATP demand and was
calculated as isometric force produced for a fixed amount of
time (newtons of force developed per gram of muscle per
minute).
Blood lactate concentrations were determined (after red
cell lysing) from the arterial and venous samples by using a
Yellow Springs Instruments 23L blood lactate analyzer. Blood
PO2, PCO2, and pH were measured within 5–8 min with a
blood-gas analyzer [model 813, Instrumentation Laboratory
(IL)] at 37°C while hemoglobin concentration ([Hb]), percent
O2 saturation, percent CO saturation, and O2 concentration
([O2]) were measured with an IL 282 CO-oximeter. These
instruments were calibrated before each experiment and
often throughout each experiment. The Fick principle was
used to calculate muscle V˙O2 and lactate efflux.
Tissue samples (40–70 mg) were deproteinized in 0.5 M
perchloric acid and neutralized. After centrifugation, the
supernatant of each sample was analyzed for [ATP], PCr
concentration ([PCr]), and creatine concentration ([creatine])
by high-performance liquid chromatography (23). The values
of [ATP] and [PCr] were normalized to the total [creatine]
([Cr] 1 [PCr]) in each individual sample. Total [creatine] has
been shown to be an excellent normalization parameter for
skeletal muscle because of its constancy at different work
intensities (4, 5). All values of [PCr] and [ATP] are reported as
a percentage of the resting values.
Statistics. Repeated-measures analysis of variance was
used for the statistical analysis. Values are expressed as
means 6 SE. In all statistical analyses, the 0.05 level of
significance was used.
RESULTS
Mean weight of the gastrocnemius muscles (n 5 5)
removed after the end of the experiment was 63 6 3
(SE) g.
The arterial PO2 (95 6 7 Torr), arterial PCO2 (45 6 2
Torr), arterial pH (7.36 6 0.02), arterial HCO3
2 concen-
tration (26 6 2 mM), arterial [Hb] (15.1 6 0.6 g/100 ml),
and arterial [O2] (17.1 6 0.8 ml/100 ml) were similar
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among muscles and did not change throughout the
experimental period. Perfusion pressure to the contract-
ing muscle was kept constant at 130 6 8 mmHg for the
three contraction periods (0.25, 0.33, and 0.5 Hz) with
normal blood flow. Muscle blood flow increased in a
linear fashion with increasing stimulation frequency
(significant increase with each change) and was re-
duced significantly (to 46% of the value obtained at 0.5
Hz with normal flow; P , 0.05) during the I condition,
as shown in Fig. 1A. Because [Hb] and arterial PO2 did
not change, O2 delivery to the muscle was proportional
to muscle blood flow and thereby mirrored the blood
flow changes seen in Fig. 1 (O2 delivery 5 11.9, 14.2,
18.0, and 8.3 ml O2·100 g21 ·min21 for the 0.25-Hz,
0.33-Hz, 0.5-Hz, and I conditions, respectively).
As illustrated in Fig. 1B, the tension-time index
(index of muscle force production for a fixed time
period) increased linearly for the three stimulation
patterns with normal blood flow (significant increase
with each change) but was significantly reduced from
the 0.5-Hz stimulation period during the I condition to
a level not significantly different from that during the
0.25-Hz stimulation period. The peak developed force
did not fall as the stimulation frequency was increased
from 0.25 to 0.33 to 0.5 Hz; peak developed force only
fell (to 65% of normal) when the I condition was
imposed. V˙O2 changes are shown in Fig. 1C and were
similar to the changes seen in the tension-time index
(Fig. 1B), with V˙O2 increasing significantly with each
stimulation frequency and then being reduced signifi-
cantly (compared with the normal flow 0.5-Hz stimu-
lation period) to a level not significantly different
from the 0.25-Hz stimulation period.
The relationship of V˙O2 to muscle blood flow is
illustrated in Fig. 2. V˙O2 was maintained in the I
condition similar to the 0.25-Hz stimulation condition,
even though blood flow was significantly less (P , 0.05),
by a significantly higher O2 extraction ratio (V˙O2/O2
delivery). In the 0.25-Hz condition, 48% of the O2
delivered was utilized by the contracting muscle com-
pared with 78% in the I condition. Figure 3 shows the
V˙O2/tension-time index relationship, which demon-
strates that the V˙O2 and tension-time index fell propor-
tionally during the I condition. In fact, there was no
significant difference in the V˙O2/tension-time index
among the three normal flow conditions (1.04 6 0.09 µl
O2/N) and the I condition (1.00 6 0.15 µl O2/N).
Figures 4 and 5 illustrate the relationship of muscle
[ATP] and [PCr] to the tension-time index and V˙O2,
respectively. Muscle [ATP] was significantly reduced
below resting values during each stimulation frequency
but was not significantly different among the three
stimulation conditions with normal blood flow. During
the I condition, muscle [ATP] was not significantly
different compared with the 0.5-Hz condition with
normal blood flow but was significantly less than that
measured during the 0.25-Hz stimulation period. Muscle
[PCr] was significantly less during all stimulation
paradigms compared with rest and it fell significantly
from the 0.25-Hz treatment to the 0.33-Hz treatment,
but it was not significantly different between the 0.33-
and 0.5-Hz stimulation periods with normal blood flow.
During the I condition, muscle [PCr] was not signifi-
cantly reduced compared with the 0.33- and 0.5-Hz
conditions with normal flow but was significantly re-
duced compared with the 0.25-Hz stimulation period.
Lactate output by the muscle was not significantly
different among the three normal blood flow conditions
and the I condition (6 6 6, 7 6 10, 20 6 13, 26 6 13
µmol·100 g21 ·min21, respectively).
Fig. 1. Relationship between muscle blood flow (A), tension-time
index (index of work performed by muscle; calculated as isometric
force produced for a fixed amount of time; B), muscle O2 uptake (V˙O2;
C), and stimulation frequency for the 3 contraction periods at which
blood flow was normal (s) and the ischemic (I; r) contraction period.
Values are means 6 SE. Correlation lines are drawn from regression
analysis (best fit) by using the 3 stimulation patterns with unre-
stricted blood flow.
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DISCUSSION
This study demonstrated that when a moderate
reduction of blood flow (to 46% of normal) was imposed
on normally perfused, aerobically contracting skeletal
muscle, force development was downregulated until
the normal relationship of mitochondrial respiration
and force production was restored. Muscle [PCr], [ATP],
and lactate efflux were not altered significantly by the I
condition compared with the same stimulation fre-
quency with normal blood flow. The insignificant
changes in these variables during these partial isch-
emic conditions, even when force production and respi-
ration were reduced by 50%, was likely due to the blood
flow reduction occurring after steady-state conditions
of respiration and force in the contracting muscle had
been established.
Relationship between V˙O2 and force production. Al-
though the regulators of mitochondrial respiration in
skeletal muscle have been well studied (4, 5, 18, 20, 22)
when O2 supply to the mitochondria is adequate, the
manner in which mitochondrial respiration and muscle
force production are coupled when O2 availability is
compromised has been less well documented. If nonoxi-
dative sources for ATP rephosphorylation are recruited
when O2 availability becomes rate limiting, then force
production can be maintained to some degree by anaero-
bic glycolysis and PCr hydrolysis (substrate-level phos-
phorylation). However, continued high rates of sub-
strate-level phosphorylation can lead to alterations in
the intracellular environment that can ultimately re-
sult in cellular damage if the ATPase activity is not
adjusted. It has been demonstrated that skeletal muscle
(12, 16, 17, 31), especially muscle rich with high-
oxidative fibers, has some capacity to minimize intracel-
lular disruption of homeostasis when O2 availability
becomes limiting by simply downregulating force pro-
duction (ATPase activity) to match flux through oxida-
tive phosphorylation, with minimal activation of sub-
strate-level phosphorylation. Although respiration and
Fig. 2. Relationship between muscle V˙O2 and muscle blood flow for
the 3 contraction periods at which blood flow was normal (s) and I
contraction period (r). Values are means 6 SE. Correlation line is
drawn from regression analysis (best fit) by using the 3 stimulation
patterns with unrestricted blood flow.
Fig. 3. Relationship between V˙O2 and tension-time index (index of
work performed by muscle) for the 3 contraction periods at which
blood flow was normal (s) and I contraction period (r). Values are
means 6 SE. Correlation line is drawn from regression analysis (best
fit) by using the 3 stimulation patterns with unrestricted blood flow.
Fig. 4. Relationship between phosphocreatine (PCr) (r, s; n 5 4)
and ATP (j, k; n 5 5; as fraction of rest values) and tension-time
index (index of work performed by muscle) for the 3 contraction
periods at which blood flow was normal (k, s) and I contraction
period (j, r). Values are means 6 SE. Correlation lines are only
drawn from regression analysis (best fit) by using the 3 stimulation
patterns with unrestricted blood flow.
Fig. 5. Relationship between PCr (r, s; n 5 4) and ATP (j, k; n 5 5;
as fraction of rest values) and V˙O2 for the 3 contraction periods at
which blood flow was normal (k, s) and I contraction period (j, r).
Values are means 6 SE. Correlation lines are only drawn from
regression analysis (best fit) by using the 3 stimulation patterns with
unrestricted blood flow.
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force production can be dramatically reduced under
these conditions, there may only be minor changes in
the intracellular concentrations of ATP, PCr, and lac-
tate. This stategy maintains the ‘‘tight coupling’’ (10) of
force production to mitochondrial respiration so that
the O2 cost of the contractions remains constant.
The manner by which muscle can minimize intracel-
lular metabolic disruption, by downregulating ATPase
activity to match the rate of oxidative phosphorylation,
during conditions of partial ischemia is not well under-
stood. Timmons et al. (28, 30) have recently demon-
strated that activating the PDC before the initiation of
an ischemic contractile period resulted in less depletion
of muscle PCr and ATP, lower lactate accumulation,
and enhanced subsequent force production compared
with the control ischemic situation with no PDC activa-
tion. This indicates that when partial ischemia was
imposed on contracting muscle at the onset of contrac-
tions, substrate availability for oxidative phosphoryla-
tion was inadequate and the reduced O2 availability
was not the only factor determining subsequent muscle
performance. The present study demonstrated that
when O2 availability was reduced after normal steady-
state conditions had been reached (fully aerobic contrac-
tions), the tight coupling of force production to respira-
tion was maintained (see Fig. 3), as has been shown
before in this highly oxidative muscle for moderate
ischemia conditions (2, 6, 8, 9, 26). Muscle [ATP], [PCr],
and lactate efflux during the I condition were not
significantly different from the values seen at the same
stimulation intensity with normal blood flow. Timmons
et al. (29) found muscle [PCr] and [ATP] to be signifi-
cantly more depleted (and found greater lactate accumu-
lation) in contracting muscle when partial ischemia
was imposed from the onset of contractions compared
with a control condition at the same stimulation fre-
quency but with normal blood flow. It is likely that in
the present study, the lack of any significant differences
in muscle [PCr], [ATP], and lactate efflux beween the I
condition and the same stimulation with normal blood
flow was due to the fact that the muscle was in a steady
state of contractile activity, with all regulatory enyzmes
fully activated, when the partial ischemia was induced.
Our results, therefore, support the notion that prior
activation of key regulatory enzymes before initiation
of partial ischemia (30) may enhance cellular homeosta-
sis and muscle function.
The question then arises as to the mechanism(s) by
which, in the present study, the muscle reduced force
development to the level at which the new steady-state
force production was exactly matched to the rate of
respiration that could be achieved from the limited
amount of O2 available. There was no fall in peak
developed force through the three normal blood flow
contraction periods (0.25, 0.33, and 0.5 Hz), and the
tension-time index increased in a linear manner with
stimulation frequency (see Fig. 1B). However, after the
reduction of muscle blood flow during the I condition,
there was an immediate (within 2–3 contractions) fall
in peak developed force until a new steady state was
established within 3–4 min at a peak force develop-
ment 65% of the value found before blood flow reduc-
tion. In this whole-muscle model, we cannot distinguish
whether the reduction in force development at the
onset of ischemia was a result of some fibers (possibly
fibers with more ‘‘fast-twitch’’ characteristics) shutting
down due to O2 deprivation (potentially from heteroge-
neous blood flow distribution) or whether all fibers
simply reduced force development proportionally. The
factors that cause the reduction in force development in
contracting muscle over time, when stimulation pat-
terns remain constant, are complex (7, 32, 34). During
contractions with ischemic blood flow reduction, there
can be an accumulation of intracellular metabolites
that can affect contractility and long-term muscle per-
formance (2, 25). However, the immediate fall in force
development in this muscle is primarily related to O2
availability (14), independent of blood flow. As dis-
cussed, there was little change in muscle Pi concentra-
tion (inversely related to [PCr]) and lactate efflux
during the I condition compared with the same stimula-
tion frequency with normal blood flow. Increased levels
of H1 and Pi have been implicated (21, 27, 33, 36) in the
rapid development of high-intensity contractile fatigue
by interfering with Ca21 release, Ca21 binding, or
actomyosin binding (see Refs. 7, 32, and 34). It is likely
that alterations in processes directly related to regula-
tion of intracellular Ca21 release were important in the
reduction of force development during ischemia in the
present study.
O2 regulation of metabolism. Although muscle [PCr]
and [ATP] were not different between the I condition
and the same stimulation frequency with normal blood
flow, these variables were significantly reduced in the I
condition compared with the 0.25-Hz condition with
normal blood flow. However, muscle V˙O2 and the tension-
time index were not significantly different (see Figs. 4
and 5) between the I condition and the 0.25-Hz condi-
tion with normal blood flow. In addition to the reduced
muscle [ATP] and [PCr] (and thereby increased Pi) at
nearly equivalent rates of respiration (V˙O2; Fig. 5) and
tension-time index (Fig. 4), the estimated [ATP]/
[ADP][Pi] ratio (ADP estimated from previous studies;
11, 13) was reduced to 25% in the I condition compared
with the value of this ratio in the 0.25-Hz condition
with normal blood flow. Thus, at the same rate of
respiration and force output, the I condition had a
significantly altered intracellular environment.
As has been demonstrated previously (2, 6, 9, 13, 26),
as blood flow was reduced in the present study the
muscle was able to extract a higher percentage of the O2
delivered by convective blood flow. A greater diffusion of
O2 to the mitochondria (for a higher extraction) was
likely accomplished by reductions in intracellular PO2.
We have suggested previously (11, 12) that various
substrates of oxidative phosphorylation may be modu-
lated by intracellular PO2 or [O2]. Rumsey et al. (24) and
Wilson et al. (35), using isolated mitochondria and
isolated cells, have demonstrated that the regulators of
oxidative phosphorylation are dependent on O2 at [O2]
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values found in the physiological range and that there
exists a wide range of O2 values that can influence the
metabolic state of the cell. For a fixed rate of respira-
tion, a higher concentration of the substrates of oxida-
tive phosphorylation may be required as tissue PO2
falls. Although other factors related to the partial
ischemia may have contributed to the very different
intracellular environment at similar V˙O2 and force
output, it is possible that differences in intracellular
PO2 had a role in modulating these factors that regulate
oxidative phosphorylation.
Conclusion. This study demonstrated that in contract-
ing, highly oxidative muscle, a moderate blood flow
reduction (with equivalent reductions in O2 availabil-
ity) reduced the tension-time index to the point at
which the normal relationship of the tension-time
index and mitochondrial respiration was restored. With
the blood flow reduction imposed after normal steady-
state conditions of blood flow, respiration, and force
output had already been achieved in a contractile
period, there was little disruption of the intracellular
environment as force was downregulated. This was
likely a result of substrate availabilty and enzymatic
processes being already adequately activated. In addi-
tion, the significant differences in muscle [ATP] and
[PCr] between the I condition and the contraction
period (0.25 Hz with normal blood flow) that had a
similar rate of respiration and tension-time index may
in part have been due to an effect of reduced intracellu-
lar PO2 on the regulators of oxidative phosphorylation.
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